Uniseed has appointed Alastair Hick as its next Chief Executive Officer, marking a new chapter in the fund’s 25-year history. He will formally take the helm in January 2026, succeeding Peter Devine, who will leave the organisation in December after 20 years in the role. …
Uniseed names Alastair Hick as new CEO to lead next phase of growth
October 29, 2025 Australian BiotechBioPharmaDispatch Executive
Latest Video
New Stories
-
OncoSil charts a new growth phase as Chairman outlines progress and opportunities
November 19, 2025 - - Latest News -
CSL unveils US expansion, cementing its position as a global biopharma leader
November 19, 2025 - - Latest News -
Cleo Diagnostics appoints U.S. oncologist as first key opinion leader
November 19, 2025 - - Australian Biotech -
IDT Australia resets strategy as advanced therapies drive new phase of growth
November 19, 2025 - - BioPharma -
Dimerix Phase 3 kidney trial clears seventh safety review
November 19, 2025 - - Australian Biotech -
Prescient secures EU orphan status for PTX-100 for cutaneous T-cell lymphomas
November 19, 2025 - - Australian Biotech -
BCAL advances early cancer detection portfolio as Australian launch looms
November 19, 2025 - - Australian Biotech